CClinicalTrials.gg
CompletedNCT02524002Updated Jun 12, 2018

Enhanced vs. Routine Clear Liquid Intake in Labor

An interventional study of Accel Gel and Usual clear diet in Abnormal Labor, Failed Induction of Labor and Ketosis, sponsored by Temple University. Completed at 1 site in United States. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-06-12.

Sponsored by Temple University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
76
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

The goal of the study is to see if the addition of a carbohydrate- and protein-enhanced gel during labor speeds labor and reduces the rate of cesarean delivery.

Read the detailed description

Patients will be randomized to placebo or experimental arm of study. In the placebo arm, patients will receive standard clear liquid diet, which includes ginger ale, variety of fruit juices, and plain soup broth. The experimental arm will receive the standard clear liquid diet, and in addition will receive Accel Gel every 3 hours while in labor.

02

Conditions studied

  • Abnormal Labor
  • Failed Induction of Labor
  • Ketosis

Browse trials for

Keywords

  • Abnormal Labor
  • Prolonged Induction
  • Ketosis
  • Diet
03

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Nulliparity (first baby)
  • Admission with the intent to deliver vaginally
  • Gestational age >36 weeks
  • Age ≥ 18

Exclusion criteria

Exclusion criteria:

  • Planned cesarean delivery
  • Renal Disease
  • Preeclampsia
  • Diabetes (Pre-gestational or Gestational)
  • Allergy to any component of sports drink
  • NPO diet by physician
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Single group
Masking
Single (Outcomes assessor)
Enrollment
76 participants (actual)

Study arms

  • Placebo comparator
    Usual Clear Diet

    This intervention consists of soup broth, variety of juices (apple, cranberry, grape), ginger ale, water, and ice.

    Dietary Supplement: Usual clear diet

  • Experimental
    Accel Gel

    This intervention is an enhanced clear liquid gel is Accel Gel, produced by PacificHealth Labs of Matawan, NJ. This gel has 4:1 carb to protein ratio formula, and ingredients that are not contraindicated in pregnancy (only the flavors with minimal caffeine are used). http://www.pacifichealthlabs.com/accel-gel-all-natural-rapid-energy-gel-product.html

    Dietary Supplement: Accel Gel

Interventions

  • Dietary supplementAccel Gel

    Accel Gel by PacificHealth Labs in Matawan, NJ.

  • Dietary supplementUsual clear diet

    Usual clear liquids

05

What researchers measure

Primary outcomes

  1. Time from admission to delivery

    Up to 3 days from time of admission

    Time frame: Participants will be followed during labor until delivery, an expected range of 1-48 hours

Secondary outcomes

  1. Duration of second stage of labor

    Time of complete cervical dilation to delivery of infant

    Time frame: Participants will be followed during labor until delivery, an expected range of 1-48 hours

  2. delivery in <24 hours

    Time frame: Participants will be followed during labor until delivery, an expected range of 1-48 hours

  3. cesarean delivery

    Time frame: Participants will be followed during labor until delivery, an expected range of 1-48 hours

  4. rate of composite adverse GI outcome (vomiting or diarrhea)

    Any vomiting or diarrhea

    Time frame: Participants will be followed for the duration of hospital stay, an expected average of 5 days

  5. patient satisfaction with diet

    Time frame: Participants will be followed during labor until delivery, an expected range of 1-48 hours

  6. Urine Ketones

    Time frame: Participants will be followed during labor until full dilation, an expected range of 1-48 hours

06

Study locations

1 site
  • Temple University Hospital
    Philadelphia, Pennsylvania 19102, United States
07

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT02524002
Lead sponsor
Temple University
Collaborators
Stanford University
Responsible party
Sponsor
First posted
Aug 14, 2015
Start date
Aug 2014
Primary completion
Jul 2017
Completion
Jul 2017
Last update
Jun 12, 2018

Study contacts

Laura Goetzl, M.D.
principal investigator · Temple University Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion